Mild Cognitive Impairment Market, By Indication (Alzheimers Disease, Vascular Dementia, Lewy Body Dementia and Parkinson Disease Dementia), By Disease Type, By Age Group, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Mild Cognitive Impairment Market size was valued at USD 1,980.21 Million in 2023, expanding at a CAGR of 5.24% from 2024 to 2032.
Mild Cognitive Impairment (MCI) is a kind of disease characterized by noticeable changes in cognitive function that are greater than expected for a person\'s age but not severe enough to interfere significantly with daily life. People with MCI might experience difficulties with memory, language, thinking, or judgment that are noticeable to themselves or others.
Mild Cognitive Impairment Market- Market Dynamics
The growing older population and advancement in diagnostic methods are expected to propel market demand
The prevalence of MCI and other cognitive disorders increases as the population rises. The growing number of older fuels demand diagnostic tools, treatments, and management strategies. There is a greater awareness and understanding of MCI among healthcare providers and the public. Advances in diagnostic methods and increased educational efforts contribute to higher detection rates and subsequent demand for interventions.
Further, increased healthcare spending on cognitive health and related areas drives demand for MCI-related products and services. Governments and private sectors are investing in better care solutions for cognitive disorders. The rise of digital health technologies, such as cognitive training apps, telemedicine, and wearable devices, enhances the management and monitoring of MCI. Technology improves patient engagement and provides new avenues for treatment and research. The development of drugs aimed at managing symptoms or modifying the progression of MCI influences market dynamics. New therapeutic agents and clinical trials contribute to growth in the pharmaceutical sector.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MILD COGNITIVE IMPAIRMENT MARKET KEY PLAYERS
Eli Lilly and Company
Biogen Inc.
Roche Holding AG
Axovant Gene Therapies Ltd.
GE Healthcare
Philips Healthcare
Neurotrack Technologies
Cogstate Ltd.
Lumosity Inc.
Alzheimer\'s Drug Discovery Foundation (ADDF)
AstraZeneca
Novartis International AG
Takeda Pharmaceutical Company Limited
Denali Therapeutics Inc.
HappyNeuron
Others
GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032
Alzheimer’s Disease
Vascular Dementia
Lewy Body Dementia
Parkinson Disease Dementia
Others
GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032
Amnestic MCI
Non-amnestic MCI
GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019-2032
Child
Adult
Geriatric
GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Mild Cognitive Impairment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Mild Cognitive Impairment Market Snippet by Indication
2.1.2. Mild Cognitive Impairment Market Snippet by Disease Type
2.1.3. Mild Cognitive Impairment Market Snippet by Age Group
2.1.4. Mild Cognitive Impairment Market Snippet by Country
2.1.5. Mild Cognitive Impairment Market Snippet by Region
2.2. Competitive Insights
3. Mild Cognitive Impairment Key Market Trends
3.1. Mild Cognitive Impairment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Mild Cognitive Impairment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Mild Cognitive Impairment Market Opportunities
3.4. Mild Cognitive Impairment Market Future Trends
4. Mild Cognitive Impairment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Mild Cognitive Impairment Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Mild Cognitive Impairment Market Landscape
6.1. Mild Cognitive Impairment Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Mild Cognitive Impairment Market – By Indication
7.1. Overview
7.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
7.1.2. Alzheimer’s Disease Dementia
7.1.3. Vascular Dementia
7.1.4. Lewy Body Dementia
7.1.5. Parkinson Disease Dementia
7.1.6. Others
8. Mild Cognitive Impairment Market – By Disease Type
8.1. Overview
8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
8.1.2. Amnestic MCI
8.1.3. Non-amnestic MCI
9. Mild Cognitive Impairment Market – By Age Group
9.1. Overview
9.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
9.1.2. Child
9.1.3. Adult
9.1.4. Geriatric
10. Mild Cognitive Impairment Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Mild Cognitive Impairment Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Mild Cognitive Impairment Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Mild Cognitive Impairment Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Mild Cognitive Impairment Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Mild Cognitive Impairment Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Mild Cognitive Impairment Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Eli Lilly and Company
11.2.2. Biogen Inc.
11.2.3. Roche Holding AG
11.2.4. Axovant Gene Therapies Ltd.
11.2.5. GE Healthcare
11.2.6. Philips Healthcare
11.2.7. Neurotrack Technologies
11.2.8. Cogstate Ltd.
11.2.9. Lumosity Inc.
11.2.10. Alzheimer\'s Drug Discovery Foundation (ADDF)
11.2.11. AstraZeneca
11.2.12. Novartis International AG
11.2.13. Takeda Pharmaceutical Company Limited
11.2.14. Denali Therapeutics Inc.
11.2.15. HappyNeuron
11.2.16. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
